Aggrastat® is a reversible antagonist of fibrinogen that binds to the glycoprotein (GP) IIb/IIIa receptor, thereby blocking the final common pathway to platelet aggregation.
Aggrastat® is ACC/AHA/SCAI Class I recommended1,2
Achieves >90% platelet inhibition within 10 minutes3
No refrigeration required, stored at room temperature
- Amsterdam EA et al. J Am Coll Cardiol. 2014;64:2645-2687
- Levine GN et al. J Am Coll Cardiol. 2011;58:e44-e122
- Mardikar HM et al. Am Heart J. 2007;154:344e1-5
